Minaris Advanced Therapies
A Principal Scientist in cell therapy process development will lead efforts to optimize and scale-up manufacturing processes, ensuring regulatory compliance and innovation. The role involves overseeing laboratory studies, applying scientific principles, and collaborating across functions to advance cell therapy products from research to commercialization.
Headquarters
Philadelphia, Pennsylvania, United States
Company Size
501-1000 employees
Founded
2025
Minaris Advanced Therapies is a contract development and manufacturing organization (CDMO) focused on end-to-end manufacturing and advanced testing for cell and gene therapies. They provide GMP manufacturing, analytical and quality testing services across development through commercial supply, supported by a global network of facilities. With 7,500+ GMP batches and roughly 40 years of testing experience, Minaris positions itself as an experienced partner for biotech and pharma companies advancing cell and gene therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Minaris Advanced Therapies.
Minaris Advanced Therapies didn’t post a salary, so this is our estimate from similar listings.
29% above the average for this role
Scientist, Cell Therapy Islet
Sana Biotechnology
Principal Research Associate, Cell Therapy Islet
Sana Biotechnology
Principal Scientist, Engineered Cell Therapy Discovery
Bristol Myers Squibb
Principal Scientist, Cell Therapy Translational Biology Research
Bristol Myers Squibb
Scientist, Cell Therapy Bioscience
AstraZeneca
Principal Scientist - Cell Therapy Translational Research
Bristol Myers Squibb